Jessica received her PhD in Biomedical Science at Victoria University of Wellington and has 11 years of experience in drug development. She specializes in advancing drug candidates from early-stage research through IND-filing and first in human clinical trials. Her work spans multiple therapeutic modalities across infectious and autoimmune diseases and oncology. In her current role at Cellics Therapeutics, Jessica leads nonclinical development focusing on pioneering cellular nanoparticles for infectious disease treatments. These cellular nanoparticles are both AMR and pathogen-agnostic, making them an innovative and promising new class of therapeutics. Jessica has authored or co-authored 26 articles and is a co-inventor on several patents.